Detail
| LncRNA Name | lncRNA00544 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | breast cancer |
| ICD-0-3 | C50 |
| Methods | Microarray, qPCR |
| Sample | luminal BC tissues, breast cancer cell lines (MCF-7, ZR751, T47D, BCAP37, SKBR3, MDA-MB-453, MDA-MB-436, MDA-MB-231, MDA-MB-231HM) |
| Expression Pattern | up-regulated |
| Function Description | Here, we aim to identify the lncRNAs which are involved in the particular type luminal BC progression. By Gene Chips analysis, we found a novel lncRNA00544, which was highly expressed in the metastatic axillary nodes compared with corresponding luminal BC tissues (fold change=2.26, P=0.043).Many differentially expressed lncRNAs including circulating lncRNA and lncRNA signatures |
| Pubmed ID | 28959047 |
| Year | 2017 |
| Title | Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+HER2 subtype breast cancer |
| External Links |
| Links for lncRNA00544 | GenBank HGNC lncrnadb Noncode |
| Links for breast cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.